Previous Page  16 / 62 Next Page
Information
Show Menu
Previous Page 16 / 62 Next Page
Page Background

Anti- CTLA-4

CA184-156 : Phase III Ipilimumab + Chemotherapy for 1L ED-SCLC (IDEATE)

N=1125

-Myers Squibb